SFA Therapeutics
YC S21 · Active · Regulating the immune system to block cancer & autoimmune diseases
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 Entelexo BiotherapeuticsShared: autoimmune disease, biotech, drugActiveOther | Other | Active | YCW21 |
 Eris BiotechShared: immune system, biotech, cancerActiveOther | Other | Active | YCW24 |
 Ditto BiosciencesShared: autoimmune disease, immune system, drugActiveAI | AI | Active | YCW26 |
 Parallel BioShared: immune system, ai-powered drug discovery, biotechActiveAI | AI | Active | YCS21 |
 Eugit TherapeuticsShared: inflammatory disease, clinical trial, biotechnologyActiveOther | Other | Active | YCS22 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Epana BioShared: autoimmune diseaseNot statedOther | Other | Not stated | SPC2025 |
 Granza BioShared: immune system, biotech, cancerActiveOther | Other | Active | YCW24 |
 Rejuvenation Technologies Inc.Shared: immune system, clinical trial, anti-agingActiveOther | Other | Active | YCS18 |
 Origami Therapeutics, Inc.Shared: oral drug, biotech, diseaseActiveOther | Other | Active | YCW22 |
 Guardian BioShared: immune system, biotech, cancerActiveOther | Other | Active | YCS22 |
Also from S21 in AI
All of S21
About SFA Therapeutics
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
- YC batch
- S21 · Summer 2021
- Status, per YC
- Active
- Category
- AI
- Team size
- 4
- Location
- Philadelphia, PA, USA
- Checked
- 1h ago
YC tags: AI-powered Drug Discovery, Anti-Aging, Biotech, Health & Wellness, Biotechnology
SFA Therapeutics: questions
Which YC batch was SFA Therapeutics in?
SFA Therapeutics was in Y Combinator's Summer 2021 batch (S21).
Is SFA Therapeutics still active?
Y Combinator lists SFA Therapeutics as active.
Where is SFA Therapeutics based?
SFA Therapeutics lists Philadelphia, PA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.